News

Juvenile arthritis can impact more than just joints affecting eyes skin and internal organs Learn about its symptoms ...
The patient’s grade 4 bullous pemphigoid emerges despite cabozantinib dose reduction, requiring high-dose corticosteroids and ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.